2022-2026 Global Hemostasis Analyzers and Reagents--USA, Europe, Japan--Chromogenic, Immunodiagnostic, Molecular Coagulation Test Volume and Sales Segment Forecasts--Competitive Shares and Growth Strategies, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Summary
This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years.
The report is available by section, and can be customized to specific information needs and budget.
The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Rationale
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
Coagulation Tests Analyzed in the Report
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrands Factor Fav/Ag, and others. Geographic Coverage
France, Germany, Italy, Japan, Spain, UK, USA
Competitive Assessments
- Extensive strategic profiles of major suppliers and emerging market entrants.
Current and Emerging Products
- Review of established and emerging procedures.
- Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.
Technology Review
- Analysis of current and emerging technologies and their potential market applications.
- Companies developing or marketing new technologies and products by test.
Strategic Recommendations
- Product development and business expansion opportunities with significant market appeal.
- Ideal product models with tentative prices and operating characteristics.
- Alternative market penetration strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.
2022-2026 Vietnam Cancer Diagnostics Market--Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
This unique database from LeadingMarketResearch.com provides information and analysis not available from any other published source, including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers.
USD 1450 View Report2022-2026 Venezuela Cancer Diagnostics Market--Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
This unique database from LeadingMarketResearch.com provides information and analysis not available from any other published source, including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers.
USD 1450 View Report2022-2026 Global Cancer Diagnostics Market in the USA, Europe, Japan--Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
This unique database from LeadingMarketResearch.com provides information and analysis not available from any other published source, including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers.
USD 9500 View Report2022-2026 Global Clinical Chemistry Market Database for the US, Europe, Japan--Supplier Shares, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and
USD 14500 View ReportFill The Form For Sample Request